Lista de obras -

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

artículo científico publicado en 2013

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

artículo científico publicado en 2013

A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis

artículo científico publicado en 2017

A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis

artículo científico publicado en 2017

A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility ⬇️

artículo científico publicado en 2015

A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis

artículo científico publicado en 2002

Adjunctive Treatment With Avacopan, an Oral C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

artículo científico publicado en 2020

Arterial lesions in giant cell arteritis: A longitudinal study

artículo científico publicado en 2018

Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis

artículo científico publicado en 2013

Cardiac Involvement in Granulomatosis with Polyangiitis

artículo científico publicado en 2015

Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitis

artículo científico publicado en 2012

Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis

artículo científico publicado en 2011

Derivation of an angiographically based classification system in Takayasu's arteritis: an observational study from India and North America

scientific article published on 03 October 2019

Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study.

artículo científico publicado en 2015

Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Controlled Study

scientific article published on 16 April 2019

Efficacy of leflunomide in the treatment of vasculitis

scientific article published on 10 November 2020

Efficacy of remission-induction regimens for ANCA-associated vasculitis

artículo científico publicado en 2013

Evaluation of Potential Serum Biomarkers of Disease Activity in Diverse Forms of Vasculitis

scientific article published on 01 September 2019

Evaluation of damage in giant cell arteritis

artículo científico publicado en 2017

Evaluation of the Safety and Efficacy of Avacopan, a C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Treated Concomitantly With Rituximab or Cyclophosphamide/Azathioprine: Protocol for a Randomized,

artículo científico publicado en 2020

Experience With Direct-to-Patient Recruitment for Enrollment Into a Clinical Trial in a Rare Disease: A Web-Based Study.

artículo científico publicado en 2017

Feasibility and Construct Validation of the Patient Reported Outcomes Measurement Information System (PROMIS) in Systemic Vasculitis

artículo científico publicado en 2019

Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis

artículo científico publicado en 2011

Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis

artículo científico publicado en 2016

Identification of Susceptibility Loci in IL6, RPS9/LILRB3, and an Intergenic Locus on Chromosome 21q22 in Takayasu Arteritis in a Genome-Wide Association Study

artículo científico publicado en 2015

Identification of multiple genetic susceptibility loci in Takayasu arteritis

artículo científico publicado en 2013

Identification of susceptibility loci for Takayasu arteritis through a large multi-ancestral genome-wide association study

scientific article published on 03 December 2020

IgA antibodies to myeloperoxidase in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss).

artículo científico publicado en 2017

Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise

artículo científico publicado en 2012

Mapping of the outcome measures in rheumatology core set for antineutrophil cytoplasmic antibody-associated vasculitis to the International Classification of Function, Disability and Health

artículo científico publicado en 2015

Neutrophil-Related Gene Expression and Low-Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

artículo científico publicado en 2015

New features of disease after diagnosis in 6 forms of systemic vasculitis

artículo científico publicado en 2013

Patterns of Arterial Disease in Takayasu's Arteritis and Giant Cell Arteritis

artículo científico publicado en 2019

Patterns of clinical presentation in Takayasu's arteritis

artículo científico publicado en 2020

Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis

artículo científico publicado en 2020

Reply

Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis

scientific article published on 24 June 2020

Rituximab versus cyclophosphamide for ANCA-associated vasculitis

artículo científico publicado en 2010

Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement

artículo científico publicado en 2014

Role of Macrophage Migration Inhibitory Factor in Granulomatosis With Polyangiitis

artículo científico publicado en 2018

Serum biomarkers in patients with relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss)

artículo científico publicado en 2015

Serum cytokine and chemokine levels in patients with eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome, or eosinophilic asthma

artículo científico publicado en 2019

Serum periostin as a biomarker in eosinophilic granulomatosis with polyangiitis

artículo científico publicado en 2018

Subglottic stenosis and endobronchial disease in granulomatosis with polyangiitis

artículo científico publicado en 2019

The Birmingham Vasculitis Activity Score as a Measure of Disease Activity in Patients with Giant Cell Arteritis

artículo científico publicado en 2016

Updating OMERACT Core Set of Domains for ANCA-associated Vasculitis: Patient Perspective Using the International Classification of Function, Disability, and Health

article

Updating the OMERACT filter: core areas as a basis for defining core outcome sets

artículo científico publicado en 2014

Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis

artículo científico publicado en 2020

Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis

artículo científico publicado en 2014

Vasculitis in patients with inflammatory bowel diseases: A study of 32 patients and systematic review of the literature

artículo científico publicado en 2015

urinary biomarkers in relapsing antineutrophil cytoplasmic antibody-associated vasculitis

artículo científico publicado en 2013

Lista de obras de

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis

A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis

A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility ⬇️

A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis

Adjunctive Treatment With Avacopan, an Oral C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

Arterial lesions in giant cell arteritis: A longitudinal study

Association of granulomatosis with polyangiitis (Wegener's) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis

Cardiac Involvement in Granulomatosis with Polyangiitis

Circulating angiopoietin-2 as a biomarker in ANCA-associated vasculitis

Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis

Derivation of an angiographically based classification system in Takayasu's arteritis: an observational study from India and North America

Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study.

Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Controlled Study

Efficacy of leflunomide in the treatment of vasculitis

Efficacy of remission-induction regimens for ANCA-associated vasculitis

Evaluation of Potential Serum Biomarkers of Disease Activity in Diverse Forms of Vasculitis

Evaluation of damage in giant cell arteritis

Evaluation of the Safety and Efficacy of Avacopan, a C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Treated Concomitantly With Rituximab or Cyclophosphamide/Azathioprine: Protocol for a Randomized,

Experience With Direct-to-Patient Recruitment for Enrollment Into a Clinical Trial in a Rare Disease: A Web-Based Study.

Feasibility and Construct Validation of the Patient Reported Outcomes Measurement Information System (PROMIS) in Systemic Vasculitis

Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis

Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis

Identification of Susceptibility Loci in IL6, RPS9/LILRB3, and an Intergenic Locus on Chromosome 21q22 in Takayasu Arteritis in a Genome-Wide Association Study

Identification of multiple genetic susceptibility loci in Takayasu arteritis

Identification of susceptibility loci for Takayasu arteritis through a large multi-ancestral genome-wide association study

IgA antibodies to myeloperoxidase in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss).

Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise

Mapping of the outcome measures in rheumatology core set for antineutrophil cytoplasmic antibody-associated vasculitis to the International Classification of Function, Disability and Health

Neutrophil-Related Gene Expression and Low-Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

New features of disease after diagnosis in 6 forms of systemic vasculitis

Patterns of Arterial Disease in Takayasu's Arteritis and Giant Cell Arteritis

Patterns of clinical presentation in Takayasu's arteritis

Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis

Reply

Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis

Rituximab versus cyclophosphamide for ANCA-associated vasculitis

Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement

Role of Macrophage Migration Inhibitory Factor in Granulomatosis With Polyangiitis

Serum biomarkers in patients with relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss)

Serum cytokine and chemokine levels in patients with eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome, or eosinophilic asthma

Serum periostin as a biomarker in eosinophilic granulomatosis with polyangiitis

Subglottic stenosis and endobronchial disease in granulomatosis with polyangiitis

The Birmingham Vasculitis Activity Score as a Measure of Disease Activity in Patients with Giant Cell Arteritis

Updating OMERACT Core Set of Domains for ANCA-associated Vasculitis: Patient Perspective Using the International Classification of Function, Disability, and Health

Updating the OMERACT filter: core areas as a basis for defining core outcome sets

Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis

Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis

Vasculitis in patients with inflammatory bowel diseases: A study of 32 patients and systematic review of the literature

urinary biomarkers in relapsing antineutrophil cytoplasmic antibody-associated vasculitis